PMC:7195088 / 29042-29428 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26","span":{"begin":27,"end":33},"obj":"Body_part"},{"id":"T27","span":{"begin":293,"end":296},"obj":"Body_part"},{"id":"T28","span":{"begin":355,"end":358},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma62872"}],"text":"Comparison of convalescent plasma plus hydroxychloroquine plus azithromycin vs. hydroxychloroquine plus azithromycin in hospitalized patients with COVID-19. Open-label RCT (NCT04332835, not yet recruiting). Primary endpoints: (a) change in virus load at days 0, 4, 7, 14 and 28; (b) change in IgM COVID-19 titers at days 0, 4, 7, 14 and 28; (c) change in IgG at days 0, 4, 7, 14 and 28."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T148","span":{"begin":147,"end":155},"obj":"Disease"},{"id":"T149","span":{"begin":297,"end":305},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of convalescent plasma plus hydroxychloroquine plus azithromycin vs. hydroxychloroquine plus azithromycin in hospitalized patients with COVID-19. Open-label RCT (NCT04332835, not yet recruiting). Primary endpoints: (a) change in virus load at days 0, 4, 7, 14 and 28; (b) change in IgM COVID-19 titers at days 0, 4, 7, 14 and 28; (c) change in IgG at days 0, 4, 7, 14 and 28."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T156","span":{"begin":27,"end":33},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T157","span":{"begin":162,"end":167},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T158","span":{"begin":227,"end":228},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T159","span":{"begin":240,"end":245},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T160","span":{"begin":280,"end":281},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"Comparison of convalescent plasma plus hydroxychloroquine plus azithromycin vs. hydroxychloroquine plus azithromycin in hospitalized patients with COVID-19. Open-label RCT (NCT04332835, not yet recruiting). Primary endpoints: (a) change in virus load at days 0, 4, 7, 14 and 28; (b) change in IgM COVID-19 titers at days 0, 4, 7, 14 and 28; (c) change in IgG at days 0, 4, 7, 14 and 28."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T383","span":{"begin":39,"end":57},"obj":"Chemical"},{"id":"T384","span":{"begin":63,"end":75},"obj":"Chemical"},{"id":"T385","span":{"begin":80,"end":98},"obj":"Chemical"},{"id":"T386","span":{"begin":104,"end":116},"obj":"Chemical"},{"id":"T387","span":{"begin":162,"end":167},"obj":"Chemical"}],"attributes":[{"id":"A383","pred":"chebi_id","subj":"T383","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A384","pred":"chebi_id","subj":"T384","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A385","pred":"chebi_id","subj":"T385","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A386","pred":"chebi_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A387","pred":"chebi_id","subj":"T387","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"Comparison of convalescent plasma plus hydroxychloroquine plus azithromycin vs. hydroxychloroquine plus azithromycin in hospitalized patients with COVID-19. Open-label RCT (NCT04332835, not yet recruiting). Primary endpoints: (a) change in virus load at days 0, 4, 7, 14 and 28; (b) change in IgM COVID-19 titers at days 0, 4, 7, 14 and 28; (c) change in IgG at days 0, 4, 7, 14 and 28."}

{"project":"LitCovid-sentences","denotations":[{"id":"T224","span":{"begin":157,"end":206},"obj":"Sentence"},{"id":"T225","span":{"begin":207,"end":386},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of convalescent plasma plus hydroxychloroquine plus azithromycin vs. hydroxychloroquine plus azithromycin in hospitalized patients with COVID-19. Open-label RCT (NCT04332835, not yet recruiting). Primary endpoints: (a) change in virus load at days 0, 4, 7, 14 and 28; (b) change in IgM COVID-19 titers at days 0, 4, 7, 14 and 28; (c) change in IgG at days 0, 4, 7, 14 and 28."}